Zacks Investment Research
19 Nov 2025, 14:21 UTC · 43w ago
Verdict
Headline takes no side. We score DLB +0.60 across five claims — strongly bullish.
+0.60strongly bullish
More positive than 75% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish
Dolby Laboratories reported Q4 fiscal 2025 non-GAAP EPS of $0.99, significantly beating the Zacks Consensus Estimate of $0.70.
More positive than 91% of claims this week
Dolby's operating income fell to $29.7 million from $46.4 million in the prior-year quarter.
So whatA significant drop in operating income suggests rising costs or margin compression, which offsets the positive top-line growth.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More negative than 81% of claims this week
Dolby's total revenues for Q4 were $307 million, exceeding the Zacks Consensus Estimate by 0.5%.
More positive than 65% of claims this week
Licensing revenues decreased 0.4% year-over-year to $281.6 million.
More negative than 66% of claims this week
Product and Services revenues grew 14.9% year-over-year to $25.4 million.
More positive than 53% of claims this week
Which stocks this story touches
More positive than 75% of ticker scores this week
The company reported non-GAAP EPS and total revenues that surpassed analyst estimates.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
2h ago
−11.5%
Price is moving against the score
$57.47 vs $64.96 close before publication (Nov 18) · not market-adjusted
DLB chart →
